+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Colustrum Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 180 Pages
  • July 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6261174
The global colostrum supplements market was valued at USD 3.80 billion in 2025 and is estimated at USD 4.01 billion in 2026, projected to reach USD 5.51 billion by 2031, at a CAGR of 6.58% during the forecast period. This report is Segmented by Source (Bovine Colostrum, Goat Colostrum, Buffalo Colostrum, and Others), Form (Capsules and Tablets, Powder, Gummies, and Others), Distribution Channel (Supermarkets/Hypermarkets, Pharmacies/Drug Stores and Health Stores, Online Retail Stores, and Other Distribution Channels), and Geography. The Market Forecasts are Provided in Both Value (USD) and Volume (Tons).

Global Colustrum Supplements Market Trends and Insights

Consumer focus on immune health and disease prevention

Growing consumer focus on immune health and disease prevention is a key driver of the global colostrum supplements market. Consumers are increasingly seeking naturally derived nutritional products that support immune resilience and overall wellness. Colostrum contains bioactive compounds such as immunoglobulins, lactoferrin, proline-rich polypeptides, and growth factors, which are widely recognized for their role in supporting immune function, making it an attractive ingredient in preventive health regimens. The increasing prevalence of immune-related disorders has further strengthened demand for supplements that help maintain immune balance. According to the Sjögren's Foundation, more than 50 million Americans, approximately 8% of the United States population, were affected by autoimmune diseases in 2025, highlighting the growing need for nutritional interventions that support immune health. This increasing consumer emphasis on proactive wellness and long-term immune support continues to accelerate the adoption of colostrum supplements worldwide.

Rising adoption of sports nutrition and muscle recovery supplements

Rising adoption of sports nutrition and muscle recovery supplements is driving the global colostrum supplements market, as athletes, fitness enthusiasts, and physically active consumers increasingly seek natural ingredients that support recovery, muscle repair, and exercise performance. Colostrum is valued for its rich content of growth factors, immunoglobulins, amino acids, and bioactive proteins that help support post-exercise recovery, maintain muscle integrity, and promote gut health during periods of intense physical activity. The growing popularity of strength training, endurance sports, and recreational fitness has encouraged manufacturers to incorporate colostrum into sports nutrition formulations. According to the Health Fitness Association (HFA), 81 million Americans belonged to a gym, studio, or other fitness facility in 2025, reflecting the expanding base of consumers regularly participating in structured fitness activities. This sustained increase in fitness participation is driving demand for scientifically supported recovery supplements, reinforcing the growth of colostrum-based sports nutrition products.

Regulatory restrictions on health and therapeutic claims

Regulatory restrictions on health and therapeutic claims are a key restraint for colostrum supplement manufacturers. Although colostrum contains bioactive compounds associated with immune and gut health, companies are generally prohibited from making claims that their products diagnose, treat, cure, or prevent diseases without regulatory approval. Compliance with labeling regulations, claim substantiation requirements, and advertising standards lengthens product development timelines and raises compliance costs. In the United States, the Food and Drug Administration (FDA) regulates dietary supplement claims under 21 CFR 101.93, which permits only specific structure/function claims accompanied by the required disclaimer and prohibits unapproved disease claims for dietary supplements. These regulatory restrictions create marketing challenges for colostrum supplement manufacturers and can slow broader consumer adoption despite growing scientific interest in the ingredient.

Other drivers and restraints analyzed in the detailed report include:

  • Demand for clean-label and naturally derived nutritional supplements
  • Growth of personalized nutrition and preventive healthcare trends
  • Supply constraints due to limited colostrum collection window

Segment Analysis

Bovine colostrum accounted for 88.61% of the colostrum supplements market in 2025, maintaining its dominant position due to its rich concentration of naturally occurring bioactive compounds and its well-established commercial production infrastructure. Its high levels of immunoglobulins, lactoferrin, growth factors, proline-rich polypeptides, and essential nutrients make it the most extensively utilized and scientifically recognized source of colostrum for nutritional formulations. Standardized collection during the initial post-calving period, combined with advanced low-temperature processing and freeze-drying technologies, enables manufacturers to preserve the biological activity of these sensitive compounds while ensuring consistent product quality. The availability of large-scale dairy supply chains, rigorous quality control protocols, and traceability systems further supports reliable sourcing and year-round production.

Goat colostrum is the fastest-growing source segment, projected to expand at a CAGR of 7.32% from 2026 to 2031, driven by increasing consumer preference for alternative dairy-derived bioactive ingredients with high nutritional value and perceived digestive compatibility. The segment is benefiting from growing interest in minimally processed, naturally sourced supplements that retain immunoglobulins, lactoferrin, growth factors, and other functional proteins. Advances in specialized collection, preservation, and low-temperature drying technologies are improving the stability and quality of goat colostrum while maintaining its bioactive profile. Manufacturers are also investing in standardized production methods and quality assurance practices to enhance consistency and strengthen consumer trust. The expanding availability of premium goat milk production systems and increasing research into the nutritional composition of goat colostrum are supporting the development of differentiated formulations.

Complete Report Scope:

  • By Source
    • Bovine Colostrum
    • Goat Colostrum
    • Buffalo Colostrum
    • Others
  • By Form
    • Capsules and Tablets
    • Powder
    • Gummies
    • Others
  • By Distribution Channel
    • Supermarkets/Hypermarkets
    • Pharmacies/Drug Stores and Health Stores
    • Online Retail Stores
    • Other Distribution Channels
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Netherlands
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • Rest of Asia-Pacific
    • South America
    • Middle East and Africa

Geography Analysis

North America held 36.91% of the colostrum supplements market in 2025, maintaining its dominant position due to the region's well-established nutraceutical industry, high consumer awareness of preventive healthcare, and strong acceptance of scientifically formulated dietary supplements. The market benefits from advanced dairy ingredient processing technologies, rigorous quality assurance standards, and continuous innovation in bioactive nutritional products. A well-developed distribution network spanning pharmacies, health stores, specialty nutrition retailers, and e-commerce platforms ensures broad product accessibility. Increasing demand for clean-label, naturally sourced, and clinically supported supplements continues to drive premium product development, further strengthening North America's position in the global colostrum supplements market.

Asia-Pacific is the fastest-growing region in the global colostrum supplements market, projected to expand at a CAGR of 7.87% from 2026 to 2031. Growth is driven by the rapid expansion of the nutraceutical industry, increasing consumer awareness of preventive wellness, and growing demand for functional nutritional products. Manufacturers across the region are investing in advanced processing technologies, bioactive ingredient preservation, and premium supplement formulations to meet evolving consumer expectations. The expansion of organized retail, digital commerce platforms, and specialty nutrition stores has significantly improved product accessibility. Continuous innovation in clean-label formulations and high-quality dairy-derived ingredients is supporting broader market penetration, collectively positioning Asia-Pacific as the fastest-growing regional market during the forecast period.

Europe holds one of the largest regional positions in the global colostrum supplements market, supported by a strong preventive healthcare culture, stringent product quality standards, and widespread consumer acceptance of food supplements. According to the European Self-Care Industry Association (AESGP), 62% of Europeans used food supplements daily in 2025, reflecting the region's mature supplement consumption habits. South America is experiencing steady growth as awareness of functional nutrition and naturally derived wellness products continues to increase, supported by improving retail infrastructure and expanding availability of premium supplements. The Middle East and Africa is also emerging as a promising market, driven by rising demand for high-quality nutritional products, expanding pharmacy and specialty health store networks, and increasing consumer focus on immunity, preventive healthcare, and overall wellness.



List of Companies Covered in this Report:

  • Pantheryx, Inc.
  • NOW Foods
  • Glanbia PLC
  • Nestle S.A.
  • Sovereign Laboratories
  • Ingredia Nutritional
  • Biostrum Nutritech Pvt. Ltd.
  • Colostrum BioTec GmbH
  • Cure Nutraceutical Pvt. Ltd.
  • Jarrow Formulas, Inc.
  • Deep Blue Health NZ
  • Good Health New Zealand Limited
  • ImmuCell Corporation
  • Vivesa holding s.r.o.
  • Biodane Pharma A/S
  • Biotaris B.V.
  • New Image Group Ltd.
  • APS BioGroup
  • The Saskatoon Colostrum Company Ltd.
  • Fitness Health Science LLC

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Consumer focus on immune health and disease prevention
4.2.2 Rising adoption of sports nutrition and muscle recovery supplements
4.2.3 Demand for clean-label and naturally derived nutritional supplements
4.2.4 Growth of personalized nutrition and preventive healthcare trends
4.2.5 Advancements in low-temperature processing and bioactive ingredient preservation
4.2.6 Expanding scientific research on bioactive compounds in colostrum
4.3 Market Restraints
4.3.1 Regulatory restrictions on health and therapeutic claims
4.3.2 Supply constraints due to limited colostrum collection window
4.3.3 Limited clinical evidence supporting certain health claims
4.3.4 Ethical concerns regarding calf nutrition and animal welfare
4.4 Consumer Behaviour Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)
5.1 By Source
5.1.1 Bovine Colostrum
5.1.2 Goat Colostrum
5.1.3 Buffalo Colostrum
5.1.4 Others
5.2 By Form
5.2.1 Capsules and Tablets
5.2.2 Powder
5.2.3 Gummies
5.2.4 Others
5.3 By Distribution Channel
5.3.1 Supermarkets/Hypermarkets
5.3.2 Pharmacies/Drug Stores and Health Stores
5.3.3 Online Retail Stores
5.3.4 Other Distribution Channels
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 Germany
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Netherlands
5.4.2.7 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.5 Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Positioning Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 Pantheryx, Inc.
6.4.2 NOW Foods
6.4.3 Glanbia PLC
6.4.4 Nestle S.A.
6.4.5 Sovereign Laboratories
6.4.6 Ingredia Nutritional
6.4.7 Biostrum Nutritech Pvt. Ltd.
6.4.8 Colostrum BioTec GmbH
6.4.9 Cure Nutraceutical Pvt. Ltd.
6.4.10 Jarrow Formulas, Inc.
6.4.11 Deep Blue Health NZ
6.4.12 Good Health New Zealand Limited
6.4.13 ImmuCell Corporation
6.4.14 Vivesa holding s.r.o.
6.4.15 Biodane Pharma A/S
6.4.16 Biotaris B.V.
6.4.17 New Image Group Ltd.
6.4.18 APS BioGroup
6.4.19 The Saskatoon Colostrum Company Ltd.
6.4.20 Fitness Health Science LLC
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pantheryx, Inc.
  • NOW Foods
  • Glanbia PLC
  • Nestle S.A.
  • Sovereign Laboratories
  • Ingredia Nutritional
  • Biostrum Nutritech Pvt. Ltd.
  • Colostrum BioTec GmbH
  • Cure Nutraceutical Pvt. Ltd.
  • Jarrow Formulas, Inc.
  • Deep Blue Health NZ
  • Good Health New Zealand Limited
  • ImmuCell Corporation
  • Vivesa holding s.r.o.
  • Biodane Pharma A/S
  • Biotaris B.V.
  • New Image Group Ltd.
  • APS BioGroup
  • The Saskatoon Colostrum Company Ltd.
  • Fitness Health Science LLC